FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

38113511000001103: Actiq 400microgram lozenges with integral oromucosal applicator (DE Pharmaceuticals) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 18-Mar 2020. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
459121000001115 Actiq 400microgram lozenges with integral oromucosal applicator (DE Pharmaceuticals) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
459141000001113 Actiq 400microgram lozenges with integral oromucosal applicator (DE Pharmaceuticals) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Actiq 400microgram lozenges with integral oromucosal applicator (DE Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (DE Pharmaceuticals) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (DE Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) parallel import indicator Parallel import true Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (DE Pharmaceuticals) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (DE Pharmaceuticals) Is a Product containing precisely fentanyl 400 microgram/1 each conventional release oromucosal lozenge (clinical drug) true Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (DE Pharmaceuticals) Is a Actiq true Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (DE Pharmaceuticals) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (DE Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category Schedule 2 (CD) true Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (DE Pharmaceuticals) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (DE Pharmaceuticals) Has specific active ingredient Fentanyl citrate true Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (DE Pharmaceuticals) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Fentanyl true Inferred relationship Existential restriction modifier
Actiq 400microgram lozenges with integral oromucosal applicator (DE Pharmaceuticals) Has dispensed dose form Lozenge true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Actiq 400microgram lozenges with integral oromucosal applicator (DE Pharmaceuticals) 30 lozenge Has AMP True Actiq 400microgram lozenges with integral oromucosal applicator (DE Pharmaceuticals) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start